21 /100
LOW RISK
Score updated Jul 13, 2026

GENI — Genius Sports Limited Dilution Risk Tracker

Track GENI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GENI — Get alerts when the score changes →

As of July 13, 2026, Genius Sports Limited (GENI) has a DilutionWatch DilutionScore of 21/100, rated LOW dilution risk. Genius Sports Limited has a market capitalization of $1.57B, 10.00M shares outstanding, 279 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
31
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GENI.
🔔 Track GENI — Get forecast alerts →

💹 Market Data

Market Cap$1.57B
Shares Outstanding10.00M
FloatN/A
Cash$280.56M
Debt$38.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 2.1% shares (2026Q1 vs prior)
279 institutional holders · 237.80M shares
#1 BlackRock, Inc. 14.64M shares
#2 Senvest Management, LLC 13.65M shares
#3 Voss Capital, LP 13.07M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest29.81M
Days to Cover3.7
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for GENI Shareholders

Genius Sports Limited (GENI) has a DilutionScore of 21/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for GENI shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for GENI in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for GENI alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track GENI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GENI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for GENI
📊 GENI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GENI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.